Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hanson
Lianyungang, Jiangsu, Chinashicl6126.goldsupplier.com ↗
- Ownership
- Private
- Employees
- ~12000
- Development stage
- Other
01
Overview
Hansoh has over 60 clinical trials across more than 40 innovative drug candidates. Seven innovative drugs have been approved with nine indications included in China's National Reimbursement Drug List as of early 2025. The company’s portfolio includes first-in-class and best-in-class therapies for oncology and other major disease areas.
- Therapeutic areas
- PsychiatryInfectious DiseasesDermatologyEndocrinologyOncology
- Modalities
- Antibody-drug conjugateSmall moleculeMonoclonal antibodyBiological productFusion proteinsiRNA-based drugs
- Industry
- Biotech
02
Partnerships
GSK – exclusive license agreement for ADCs including HS‑20093 & HS‑20089MSD/Merck – out-license collaborations on undisclosed assetsRegeneron – out-license collaborations on undisclosed assetsSilence Therapeutics – collaboration on siRNA therapeutics using mRNAi GOLD™ platform ($16M upfront + milestones)
Beyond the preview
Go deeper on Shanghai Hanson.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Hanson.